Founder of French breast implant scandal firm jailed (Update 2)

December 10, 2013 by Anne Beade

The founder of a French firm whose faulty breast implants sparked a global health scare was sentenced to four years in jail Tuesday after being convicted of fraud.

Four other former executives of the now-defunct Poly Implant Prothese (PIP) were also convicted over a scandal that reverberated around the world.

PIP was revealed two years ago to have been systematically using industrial-grade rather than medically approved silicone in its breast implants in order to cut costs and boost profits.

The Marseille court sentenced PIP founder Jean-Claude Mas to four years in prison, fined him 75,000 euros ($103,000) and banned him permanently from working in medical services or running a company.

The 74-year-old, who says he is insolvent, was also ordered to compensate more than 4,000 plaintiffs up to 13,000 euros each for the anxiety he had caused them and, in some cases, the physical trauma of having the implants removed.

Mas, who was dubbed "the sorcerer's apprentice of implants" by prosecutors, did not react as the verdict was read out in court.

"Jean-Claude Mas did not fear for about 10 years to sell breast implants which contained a gel... made using uncertain procedures," the court said, adding that they had not been subjected to "obligatory tests and examinations".

His lawyer, Yves Haddad, blamed the severity of the sentence on media-generated pressure and said he would appeal, a move which will keep Mas out of prison pending the outcome of a further hearing.

Haddad said it was "shocking" that Mas had not been given a suspended sentence as he had no previous criminal record.

The scandal first emerged in 2010 after doctors noticed abnormally high rupture rates in PIP implants.

It gathered steam worldwide in 2011, with some 300,000 women in 65 countries believed to have received the faulty implants.

During a month-long trial in April, the defendants admitted to using the industrial silicone but Mas denied the company's implants posed any health risks.

More than 7,500 women have reported ruptures in the implants and in France alone 15,000 have had the PIP implants replaced.

But health officials in various countries have said they are not toxic and do not increase the risk of breast cancer.

Several dozen of the women who had brought civil actions against Mas and PIP were in court Tuesday for the verdict.

"It is an important symbolic first step—the first time that we can use the word 'guilty' for Jean-Claude Mas," said Alexandra Blachere, the head of an association of women given the implants.

"It is a relief for the victims to be recognised," said Philippe Courtois, a lawyer for many of them, hailing the court's "rapid and coherent response".

Industrial gel saved PIP millions

The court also sentenced PIP's former general manager Claude Couty to three years in prison, with two years suspended.

Quality control director Hannelore Font and production director Loic Gossart were both sentenced to two years in prison, with one suspended, and research director Thierry Brinon was given an 18-month suspended sentence.

The executives are also partly liable for the damages award made Tuesday, although it was unclear if any of them would be capable of paying.

The court said Mas ran a tight ship and that "it was particularly difficult to go against his decisions and orders". It added that he was the "main beneficiary" of the money obtained through fraud.

Mas, a one-time travelling salesman who got his start in the medical business by selling pharmaceuticals, founded PIP in 1991 to take advantage of the booming market for cosmetic implants.

He built the company into the third-largest global supplier of implants. He came under the spotlight when plastic surgeons began reporting an unusual number of ruptures in his products.

Health authorities later discovered he was saving millions of euros by using industrial-grade gel in 75 percent of the implants.

Implants must be made from medical grade material that has been approved for use in a human body.

PIP's implants were banned and the company eventually liquidated.

PIP had exported more than 80 percent of its implants, with about half going to Latin America, about a third to other countries in western Europe, about 10 percent to eastern Europe and the rest to the Middle East and Asia.

Some of the defendants, including Mas, have also been charged in separate and ongoing manslaughter and financial fraud investigations into the scandal.

The manslaughter probe is related to the suspicious 2010 death from cancer of a woman who was fitted with the implants.

Explore further: French court finds German firm liable in implants scandal (Update)

Related Stories

French court finds German firm liable in implants scandal (Update)

November 14, 2013
A French court on Thursday found German safety standards firm TUV liable in a worldwide scare over defective breast implants and ordered the company to compensate distributors and hundreds of victims.

Prosecutor urges 4-year sentence for faulty breast implants

May 14, 2013
A French prosecutor on Tuesday called for the founder of a firm whose faulty breast implants sparked a global health scare to be given a four-year prison sentence on fraud charges.

Founder of faulty breast implants firm denies risking lives (Update)

April 19, 2013
The founder of a firm whose faulty breast implants sparked a global health scare told a French court Friday he had not put any lives at risk, as other defendants described him as a controlling "know-it-all".

French executives on trial over faulty breast implants (Update)

April 17, 2013
France launched one of its biggest-ever trials on Wednesday as five managers from company PIP faced charges of selling faulty breast implants that sparked a global health scare.

Breast implant scare: One in four found flawed

June 25, 2013
Doctors in France have removed PIP breast implants from more than 16,000 women and found a quarter of the scandal-tainted products had signs of splitting or leakage, a watchdog said on Tuesday.

German firm on trial over faulty French breast implants

March 22, 2013
Proceedings against a German safety standards firm that gave defective breast implants the all clear kicked off Friday in France, with millions of euros claimed in damages.

Recommended for you

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

Best of Last Year – The top Medical Xpress articles of 2016

December 23, 2016
(Medical Xpress)—It was a big year for research involving overall health issues, starting with a team led by researchers at the UNC School of Medicine and the National Institutes of Health who unearthed more evidence that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.